IL42790A - 4a-aryl-trans-decahydroisoquinolines their preparation and pharmaceutical compositions containing them - Google Patents

4a-aryl-trans-decahydroisoquinolines their preparation and pharmaceutical compositions containing them

Info

Publication number
IL42790A
IL42790A IL42790A IL4279073A IL42790A IL 42790 A IL42790 A IL 42790A IL 42790 A IL42790 A IL 42790A IL 4279073 A IL4279073 A IL 4279073A IL 42790 A IL42790 A IL 42790A
Authority
IL
Israel
Prior art keywords
compound
trans
formula
decahydroisoquinoline
administering
Prior art date
Application number
IL42790A
Other versions
IL42790A0 (en
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of IL42790A0 publication Critical patent/IL42790A0/en
Publication of IL42790A publication Critical patent/IL42790A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Claims (30)

CLAIMS The embodiments of the invention in which an exclusive property or privilege is claimed are defined follows:
1. A compound of the formula A · v/herein R1 is hydrogen, Cj-Cg alkyl, benzyl, phenethyl, or cycloalkylmethyl of the formula -CH2CH < (CH2)n in which n is an integer in the range 2 R is divalent oxygen , A is hydrogen or hydroxy ; Claim 1 (continued) in which 3 R is hydrogen, hydroxy.or methoxy; 4 R is 'hydroxy or methoxy j
2. A compound according to claim 1 which is dextrorotatory.
3. A compound according to claim 1 which is laevorotatory.
4. The compound of claim 1 which is N-methyl-4a-phenyl-trans-decahydroisoquinoline.
5. The laevo isomer of the compound of claim 4.
6. The dextro isomer of the compound of claim 4.
7. The compound of claim 1 which is N-methyl-4a( methoxyphenyl)-trans-decahydroisoquinoline.
8. · The compound of claim 1 which is N-methyl-4a-(m-hydroxyphenyl)-trans-decahydroisoquinoline.
9. The compound of claim 1 which is N-methyl- a-phenyl-Sa-hydroxy-trans-decahydroisoquinoline.
10. The compound of claim 1 which is N-cyclohexyl-methyl-a-phenyl-trans-decahydroisoquinoline.
11. The compound of claim 1 which is N-phenethyl- a (m-metho:yphenyl)-trans-decahydroisoquinoline.
12. The compound of claim 1 which is N-phenethyl-i+a (m-hydroxyphenyl)-trans-decahydroisoquinoline .
13. A process for preparing a compound of the formula wherein H R is hydrogen, C-j-C^ al-kyl, benzyl, phenethyl, or cycloalkylmethyl of the formula -CH,CH :(CH2)n in which n is an integer in the range 2-5» Ar1 is in which 7 . R is hydrogen or'methoxy and K is methoxy. said process comprising the sequential steps of (a) contacting a compound of the formula with an anhydrouc alcohol of the formula RD0H, wherein R^ is alkyl of 1-4 carbons, in the presence of anhydrous HC1, under inert, anhydrous conditions at a temperature in the range of 50-120°C to form the corresponding diketo derivative of the formula (b) heating the diketo product of step (a) with sodium hydride and a halide R^Br or R"" I to form the corresponding N-substituted derivative of the formula contacting the N-substituted >roduct of step (b) V7ith hydrogen in the presence of a reducing catalyst to form the correspond inn; trnriD diheto derivative of tne formula (d) refluxing the trans derivative of step (c) with lithium aluminum hydride to form the desired product
14. , A process for the preparation of a compound the formula which comprises the sequential steps of (a) heating a compound of the formula with chloroperbenzoic acid to produce an epoxy compound of the formula 42790/2 heating the epoxy product of step (a) with lithium aluminum hydride to form the desired product wherein R is hydrogen, C-^-Cg alkyl, benzyl, phenethyl, or cycloalkylmethyl of the formula -CH^CH < (CH2)n in which n is an integer in the range 2-5» Ar is in which R is hydrogen or methoxy and o R is methoxy. 42790/2
15.» An analgesic composition comprising an effective analgesic amount of a compound of claim 1 and a pharmaceutically acceptable carrier.
16. The composition of claim 15 in which the compound is N-methy 1-^a-phenyl-trans-decahydroisoquinoline .
17. The composition of claim 15 in which the compound is N-methyl-¾a-(m-methoxyphenyl)-trans-decahydroiso-quinollne.
18. ·. The composition of claim 15 in which the compound is N-methyl-¾a-(m-hydroxyphenyl)-trans-decahydroiso-quinoline.
19. ·, The composition of claim 15 in which the compound is N-methy1-^a-pheny l-8a-hydroxy-trans-decahydroiso-quinoline .
20.. The composition of claim 15 in which the compound is N-cyclohex lmethyl-i+a-phenyl-trans-decahydroiso-quinoline.
21.. The composition of claim 15 in which the compound is N-phenethyl- a-(m-methoxyphenyl)-trans-decahydro- isoquinoline.
22. The composition of claim 15 in which the* compound is N-phenethyl- a-(m-hydroxyphenyl)-trans-decahydro- 42790/2
23. A method of producing analgesia which consists essentially of administering to a warm-blooded animal an effective amount of a compound of claim 1.
24. A method of producing analgesia which consists essentially in administering to a warm-blooded animal an effective amount of_a- compounds of claim .
25.. A method of producing analgesia which consists essentially in administering to a warm-blooded animal an effective amount of a compound of claim 7.
26. A method of producing analgesia which consists essentially in administering to a warm-blooded animal an effective amount of a compound of claim 3.
27. A method of producing analgesia which consists essentially in administering to a warm-blooded animal an effective amount of a compound of claim 9.
28. A method of producing analgesia which consists essentially in administering to a warm-blooded animal an effective amount of a compound*l.of claim 10.
29. A method of producing analgesia which consists essentially in administering to a warm-blooded animal an effective amount of a compound of claim 11.
30. A method of producing analgesia which consists essentially in administering to a warm-blooded animal an
IL42790A 1972-07-20 1973-07-19 4a-aryl-trans-decahydroisoquinolines their preparation and pharmaceutical compositions containing them IL42790A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27380672A 1972-07-20 1972-07-20
US36584373A 1973-06-01 1973-06-01

Publications (2)

Publication Number Publication Date
IL42790A0 IL42790A0 (en) 1973-10-25
IL42790A true IL42790A (en) 1976-11-30

Family

ID=26956443

Family Applications (3)

Application Number Title Priority Date Filing Date
IL42790A IL42790A (en) 1972-07-20 1973-07-19 4a-aryl-trans-decahydroisoquinolines their preparation and pharmaceutical compositions containing them
IL48667A IL48667A (en) 1972-07-20 1973-07-19 4a-aryl-1,3-diketo-trans-decahydroisoquinolines and 4a-aryl-1,3-diketo-1,2,3,4,4a,5,6,7-octahydroisoquinolines and their preparation
IL48667A IL48667A0 (en) 1972-07-20 1975-12-15 4alpha-aryl-1,3-diketo-trans-decahydroisoquinolines and 4alpha-aryl-1,3-diketo-1,2,3,4,4alpha,5,6,7-octahydroisoquinolines and their preparation

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL48667A IL48667A (en) 1972-07-20 1973-07-19 4a-aryl-1,3-diketo-trans-decahydroisoquinolines and 4a-aryl-1,3-diketo-1,2,3,4,4a,5,6,7-octahydroisoquinolines and their preparation
IL48667A IL48667A0 (en) 1972-07-20 1975-12-15 4alpha-aryl-1,3-diketo-trans-decahydroisoquinolines and 4alpha-aryl-1,3-diketo-1,2,3,4,4alpha,5,6,7-octahydroisoquinolines and their preparation

Country Status (13)

Country Link
JP (1) JPS4985075A (en)
AR (1) AR208650A1 (en)
CA (1) CA1024149A (en)
DE (2) DE2351599A1 (en)
ES (1) ES417127A1 (en)
FR (1) FR2193600B1 (en)
GB (2) GB1436377A (en)
HU (1) HU167738B (en)
IE (1) IE37929B1 (en)
IL (3) IL42790A (en)
LU (1) LU68066A1 (en)
NL (1) NL7310078A (en)
SE (1) SE7602150L (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7509337L (en) * 1974-09-23 1976-03-24 Du Pont PAINING ASSOCIATIONS
BG30927A3 (en) * 1977-12-27 1981-09-15 Eli Lilly And Company Method for obtaining of trans- 4- alpha- phenyl- octahydro- 1h- 2- pyridine
KR950002885B1 (en) * 1990-06-05 1995-03-28 토레이가부시키가이샤 Indole derivatives
CA2112744A1 (en) * 1991-07-05 1993-01-21 Vittorrio Vecchietti Hydroisoquinoline derivatives
IT1307327B1 (en) * 1995-09-12 2001-10-30 Smithkline Beecham Spa REPLACED HYDROISOKINOLINIC DERIVATIVES

Also Published As

Publication number Publication date
GB1436377A (en) 1976-05-19
ES417127A1 (en) 1976-04-01
IE37929B1 (en) 1977-11-09
CA1024149A (en) 1978-01-10
AU5820773A (en) 1975-01-23
IL48667A0 (en) 1976-02-29
FR2193600A1 (en) 1974-02-22
NL7310078A (en) 1974-01-22
DE2351599A1 (en) 1974-01-31
LU68066A1 (en) 1973-09-26
IL48667A (en) 1976-11-30
IL42790A0 (en) 1973-10-25
HU167738B (en) 1975-12-25
DE2336559A1 (en) 1974-01-31
FR2193600B1 (en) 1976-10-22
IE37929L (en) 1974-01-20
AR208650A1 (en) 1977-02-28
GB1436376A (en) 1976-05-19
JPS4985075A (en) 1974-08-15
SE7602150L (en) 1976-02-23

Similar Documents

Publication Publication Date Title
DE3170245D1 (en) Indane derivatives, methods of their preparation and compositions containing them
JPH05310734A (en) Emesis inhibitor
IL42790A (en) 4a-aryl-trans-decahydroisoquinolines their preparation and pharmaceutical compositions containing them
GB1374367A (en) Propionamide derivative a method of making it and therapeutic compositions containing it
PT79207A (en) Process for preparing spiro-tricyclicaromatic succinimide derivatives useful as inhibitors of aldose reductase
GB1062714A (en) -ß-(4&#39;-acyloxy-4&#39;-piperidyl)-ketones
US4501752A (en) Antiulcer drug
US3746495A (en) Anti-ulcer therapy
ES8308833A1 (en) Novel 3-phenyl-1-indanamines, pharmaceutical compositions and methods of preparation.
EP0440098B1 (en) Optically active derivative of d-2-(6-methoxy-2-naphthyl)-propionic acid and pharmaceutical compositions containing it
ES437790A1 (en) Therapeutic compositions containing methylamine derivatives or their salts
GB1142508A (en) Pyrrole derivatives
ES8207517A1 (en) Bicyclooctane derivatives, processes for producing them, pharmaceutical compositions containing them, their use as pharmaceuticals and precursors thereof.
CA1041516A (en) Process for the preparation of 1,3,4-trimethyl-2-(3,4,5-trimethoxybenzyl)-1,2,5,6-tetrahydropyridine
IL38440A (en) 2-(4,4-ethylenedioxypiperidinoethyl)-3-halophenyl-2-imidazolidinones,their preparation and pharmaceutical compositions containing them
US3795736A (en) 5,5-dimethyl-10-hydroxy-8-(3-methyl-2-octyl)-2-(2-propynyl)-1,2,3,4-tetrahydro-5h-(1) benzopyrano(3,4-d)pyridine as an analgesic agent
ES441207A1 (en) Decahydroisoquinoline derivatives processes for their prepa ration and their use in pharmaceutical compositions
US3860608A (en) 3-aminoalkyloxyindoles
JPS6124593A (en) Pyrimidoisoquinoline derivative
JPS6042375A (en) Propan-2-ol derivative, manufacture and drug containing same
GB1464082A (en) Pharmaceutical &#39;ompositions containing benzylamines
US3763184A (en) Pharmaceutically active pyrrolidino naphthothiophenes
HU174772B (en) Process for producing pharmaceutically active acetic acid derivatives
KR790001521B1 (en) Process for preparation of benzylamines
GB1230673A (en)